Spikevax
AssetAlso mRNA-1273
Lipid nanoparticle-delivered mRNA encodes SARS-CoV-2 spike protein to induce protective immunity.
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Not known
- 1
- Indication
- 2
- Trials
- 2
- Developers
Indications
1Sars cov 2
Phase 3, Recruiting, NCT07863635, clinicaltrials.gov, Oct 28, 2026
In the full profile
- Owner and partners2
- Trials2
- Evidence for its targets1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.